-transparent.png){kind=logo}
Human recombinant interferon-alpha 2C was given to 4 patients with essential thrombocythaemia. Three patients achieved a complete remission on day 19 +/- 1 and the 4th achieved a partial remission. After 4 weeks of induction therapy, a maintenance therapy of twice weekly intramuscular injections of 5 X 10(6) or 10 X 10(6) IU was instituted but did not maintain the remission.
Related Publications
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
January 1994,
Acta haematologica,
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
January 1985,
Oncology,
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
January 1990,
Leukemia & lymphoma,
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
January 1987,
Haematologica,
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
July 1988,
Lancet (London, England),
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
May 1996,
British journal of haematology,
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
January 1991,
European journal of cancer (Oxford, England : 1990),
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
January 1989,
Lancet (London, England),
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
October 1988,
Lancet (London, England),
T Velu, and
F Delwiche, and
D Gangji, and
R Monsieur, and
J Flament, and
P Stryckmans, and
J Wybran, and
R Bellens
October 1991,
British journal of haematology,
